EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN PATIENTS WITH DECOMPENSATED HEPATITIS B CIRRHOSIS

被引：0
|
作者：
Deng, You [1 ]
Cui, Weili [2 ]
Yue, Jin [3 ]
Li, Jinlong [4 ]
Zhang, Shuqian [1 ]
Wang, Qi [1 ]
Zhao, Hong [1 ]
Chen, Wenya [1 ]
Li, Jiashuo [1 ]
Li, Mengqi [1 ]
Lai, Xiaohuan [4 ]
Guo, Xiaoqing [3 ]
Qiao, Bing [2 ]
Xie, Wen [1 ]
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[2] Qingdao Sixth Peoples Hosp, Qingdao, Peoples R China
[3] Third Peoples Hosp Taiyuan, Taiyuan, Peoples R China
[4] Ganzhou Fifth Peoples Hosp, Ganzhou, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2241
引用
收藏
页码：S1696 / S1697
页数：2
相关论文
共 50 条
  • [31] One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B An observational study
    Chen, Yi-Cheng
    Hsu, Chao-Wei
    Chien, Rong-Nan
    Tai, Dar-In
    MEDICINE, 2022, 101 (25) : E29269
  • [32] Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment of patients with HIV and Hepatitis B Virus (HBV) coinfection
    Huang, Y-S
    Lee, C-H
    Lee, Y-T
    Sun, H-Y
    Liou, B-H
    Yang, C-J
    Liu, C-E
    Tang, H-J
    Lin, S-P
    Cheng, C-Y
    Cheng, S-H
    Lu, P-L
    Ho, M-W
    Huang, S-H
    Tsai, H-C
    Hung, C-C
    HIV MEDICINE, 2019, 20 : 292 - 293
  • [33] Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?
    Oh, Hyunwoo
    Jun, Dae Won
    GUT AND LIVER, 2017, 11 (06) : 743 - 744
  • [34] Efficacy of entecavir in naive patients with chronic hepatitis B and decompensated liver cirrhosis
    Kao, J-T
    Peng, C-Y
    Lai, H-C
    Chuang, P-H
    Su, W-P
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A202 - A202
  • [35] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Lesley J. Scott
    Henry L. Y. Chan
    Drugs, 2017, 77 : 1017 - 1028
  • [36] Tenofovir alafenamide for hepatitis B: evolution or revolution?
    Brouwer, Willem P.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03): : 174 - 175
  • [37] Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice
    Curry, Michael
    Bae, Ho
    Dieterich, Douglas
    Ankoma-Sey, Victor
    Reddy, Rajender
    Pan, Calvin
    Hann, Hie-Won
    Tong, Myron
    Kim, W. Ray
    Kwo, Paul
    Frazier, Lynn
    Milligan, Scott
    Spitz, Keith
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E462 - E462
  • [38] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
    Schwarz, Kathleen B.
    Bezerra, Jorge A.
    Choe, Byung-Ho
    Lin, Chuan-Hao
    Abramov, Frida
    Nguyen, Anh-Hoa
    Liu, Yang
    Flaherty, John F.
    Pacurar, Daniela
    Kim, Kyung Mo
    Khaertynova, Ilsiyar
    Shalimar
    Wu, Jia-Feng
    Tandon, Manish
    Rosenthal, Philip
    Morozov, Viacheslav
    Sokal, Etienne
    Chang, Mei-Hwei
    HEPATOLOGY, 2022, 76 : S300 - S301
  • [39] Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B
    He, Feng
    Xia, Zhongjiang
    Wang, Hui
    Zhu, Jinjun
    Hu, Laiwen
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [40] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Scott, Lesley J.
    Chan, Henry L. Y.
    DRUGS, 2017, 77 (09) : 1017 - 1028
12345